Natco Pharma launches drug for prostate cancer
Hyderabad-based Natco Pharma Ltd has announced the launch of a drug to treat prostate cancer in the 140-mg capsules form under the brand 'X-trant' (estramustine). In a press release, Natco Pharma
Hyderabad-based Natco Pharma Ltd has announced the launch of a drug to treat prostate cancer in the 140-mg capsules form under the brand 'X-trant' (estramustine). In a press release, Natco Pharma